SS-31 (10mg)

SS-31 (also known as elamipretide) is a peptide that targets the mitochondria — the power-generating structures inside every cell. As we age, mitochondria become less efficient, and this decline underlies a wide range of age-related problems: lower energy, weaker muscles, poorer heart function, reduced cognitive performance. SS-31 works by protecting a key component inside the mitochondrial membrane that the energy production machinery depends on. It's studied across cardiology, neurology, and longevity research because fixing mitochondrial function addresses the root cause shared by so many age-related conditions.

SS-31 is also called elamipretide — the name used in clinical trial literature. You may also see the older code MTP-131 in some publications. All three names refer to the same compound.

Your mitochondria produce energy through a process that relies on a tightly organised inner membrane. A molecule called cardiolipin holds that structure together — but it gets damaged by oxidative stress and deteriorates with age. SS-31 binds to cardiolipin and stabilises it, helping the mitochondria maintain their structure and produce energy efficiently. In plain terms: it helps the cell's power plant run cleanly again, rather than producing energy wastefully and generating damaging byproducts.

SS-31 is researched for anyone interested in addressing the mitochondrial component of ageing — which covers a lot of ground. Researchers studying age-related fatigue, cardiac decline, muscle endurance, cognitive performance, and longevity all reach for SS-31 because mitochondrial dysfunction is a common thread across all of these. It's also studied in acute contexts like heart attack recovery and kidney injury, where rapid mitochondrial protection matters.

Studies have shown SS-31 improving cardiac function in heart failure models, reducing muscle fatigue and improving physical endurance in aged animals, protecting kidney tissue from injury, preserving neuronal energy metabolism, and reversing measurable aspects of mitochondrial ageing. In some models, SS-31 treatment produced functional improvements in aged tissue comparable to what you'd expect from much younger tissue. It's one of the most clinically advanced mitochondria-targeted compounds in development, with trials ongoing in heart failure and other conditions.

Both target mitochondrial function but through different mechanisms. NAD+ replenishes a coenzyme that the mitochondria need to produce energy — think of it as restocking a key fuel supply. SS-31 targets the physical structure of the mitochondrial membrane itself — it repairs the environment where energy production happens. Many researchers see them as complementary: NAD+ provides the fuel, SS-31 helps the engine run properly.

SS-31 is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) immediately before use. Inject the BAC water slowly into the vial, directing the stream down the inside wall. Gently swirl to dissolve — do not shake. Once reconstituted, store at 2–8°C and use within 8–12 weeks. For a full step-by-step walkthrough, see our complete peptide reconstitution guide.

Store lyophilized SS-31 vials at -20°C, away from light and moisture. After reconstitution with BAC water, refrigerate at 2–8°C and use within 8–12 weeks. Do not freeze the reconstituted solution.

SS-31 (10mg) is available through Aussie Peptides with fast domestic shipping to all Australian states and territories. Every vial is dispatched from within Australia — no customs delays, no international freight. Batch-specific Certificate of Analysis access is available in our CoA library.

SS-31 (10mg) is priced at $89.99 per vial at Aussie Peptides. All orders ship domestically within Australia, and batch CoAs are available in our CoA library.